John E. Mullinax - Concepedia

Author

John E. Mullinax

Also Known As

F Reid, Hao Liu, I Ganly, J Mullinax, J. Mullinax, J.E. Mullinax, JE Mullinax, John E Mullinax, John E. Mullinax, John Mullinax

163

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center University of South Florida National Cancer Institute National Institutes of Health Center for Cancer Research

About

John E. Mullinax is an author at Moffitt Cancer Center specializing in medicine, surgery, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.1K
2	Cell Biology	4	4	152
3	Health Sciences	2	2	81
4	Cellular Therapies	1	1	46
5	Emergency Medicine	1	1	26

John E. Mullinax

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial Ben Creelan, Chao Wang, Jamie K. Teer, Nature Medicine Tumor-infiltrating Lymphocyte TreatmentCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2021	400
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma Michael D. Jain, Hua Zhao, Xuefeng Wang, Blood	2021	273
Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial Udo Rudloff, Russell C. Langan, John E. Mullinax, Journal of Surgical Oncology	2014	227
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group Carol J. Swallow, Sylvie Bonvalot, Piotr Rutkowski, Annals of Surgical Oncology Surgical OncologyPrimary Retroperitoneal SarcomaSurgical PathologyPathologyConsensus Approach	2021	224
Label-retaining liver cancer cells are relatively resistant to sorafenib Hong-Wu Xin, Chenwi M. Ambe, Danielle M. Hari, Gut	2013	107
Survival After Pancreaticoduodenectomy is not Improved by Extending Resections to Achieve Negative Margins Jonathan M. Hernandez, John E. Mullinax, W. Edwin Clark, Annals of Surgery	2009	104
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran, Frontiers in Oncology	2018	94
Colorectal Cancer Biomarkers and the Potential Role of Cancer Stem Cells Russell C. Langan, John E. Mullinax, Manish T. Raiji, Journal of Cancer	2013	82
Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel Rawan Faramand, Michael D. Jain, Verena Staedtke, Clinical Cancer Research	2020	79
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization G.Q. Yang, Zhigang Yuan, Kamran A. Ahmed, Translational Oncology	2021	69

Page 1